Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doubt either of those will ever materialize. IR needs to give an update.
April 16th and no news about overseas shipping in march and contracts yet. No news from IR or any tweets in weeks. Anyone hear from the IR guy?
You can barely read anything on the site and it looks like a hack job.
Most likely on April 1st if all the 2023 filings are not submitted.
The old website was a lot better IMO. Not even sure what their business angle is now. Did they move into pet health for veterinarians? Vitastem is being used to treat horses, cows, sheep, rabbits, and chickens too?
Agree. At this point it's on the company's management to come through on all the sales deals, partnerships, and filings that they've put out there.
Hopefully we get the expected updates within the next few days based on their last PR.
The data is from FINRA
The low volume would not indicate that.
There is A LOT of short volume on VDRM.
Start buying whale.
Oh. Then who is buying the shares up?
Bid sitters getting filled? Shorts covering positions?
If there's sellers, there's buyers. Simple.
Likely low bids and shorts covering.
https://www.otcshortreport.com/company/VDRM
That tip must have come from an unnamed source that heard the CEO screaming to someone in the office.
You know how he heard it from a guy, whose cousin's friend's sister's friend told him about this.
You are right.
OTC is likely waiting on the attorney letter as supplement to the filings. Once that comes in the yield sign is removed within days of receipt.
Viaderma is notorious for moving slow, but eventually come through.
Looks like the MMs are dropping the price a bit today to scoop up shares or short sellers closing out positions too.
A lot of short volume the past few days https://www.otcshortreport.com/company/VDRM
Bid sitters aren't getting filled because there's no high volume sellers.
Gotta hit the ask if you want to get filled. Many will be chasing this at much higher prices soon.
The minnow is pissed and rightfully so. All emotion and no substance.
Sucks selling low and having to chase to buy back in higher.
The good 'ol sell low, chase, and buy back in high scenario. LOL
They literally told everyone in PRs and tweets updates were coming and people still bash and sell low.
Bless their hearts.
OTC filings finally updated per VDRM tweet. Next updates coming: stability testing completion and moving forward with international sales for Vitastem.
Update: $VDRM filings have been submitted to #OTCMarkets. Further updates on stability testing requirements completion and moving forward with international sales distribution for @vitastem are coming soon.
— ViaDerma (@viaderma) January 23, 2024
I heard it from a guy, who heard it from another guy, who heard it from his cousin, who heard it from their friend, who heard it from a guy in his office, who heard it from some guy who heard otiko say it.
It's legit!
Totally agree with this one.
They're notorious for delayed filings, but always come through eventually.
The last PRs seemed positive and a few of their recent tweets too. We'll have to wait and see, but feel the tide is finally turning here and we'll get a few updates soon. Breaking into big pharma deals are not easy and can take a very long time to realize since they move very slow with DD and agreements. The international deals look very promising and should open even more doors overseas and in the US too. IMO
BIG TBD but trying to stay positive here.
Big pharma moves very slowly. They likely won't get acquired this year, but as licensing and product sales grow in the US and internationally, the big pharma engagement with VDRM should pick up where an acquisition will become more likely.
There's a lot of stuff in the works here and we should be getting several updates near the end of the month for the otc filings, stability testing, and vitastem shipments to egypt, india, middle east based on their most recent PRs and tweets. IMO those news updates will help open up some doors to larger wholesale distributors like a cardinal health in the US too and those wholesalers having thousands of sales reps could generate millions in new sales pretty quickly.
Hopefully we'll get some much needed news very soon and a positive outlook for this year.
Sure bruv. Super believable.
So what city did this meeting take place in then?
Really? LinkedIn is not a reliable source? LOL
https://www.linkedin.com/in/garrettradams who's this guy then?
The reality is follow their updates on X https://twitter.com/viaderma and recent PRs.
And where did this closed door meeting occur?
or you can just go to linkedin.
otc markets doesn't update very often.
Rainmaker is right.
Adams is the president and Otiko is the CEO.
The last tweets said end of January so updates are likely coming in the next two weeks. I'd assume they'll have a lot to share with everyone. Filings, stability testing and international sales. Maybe more too? TBD
It doesn't seem like they have a real solid plan to grow the business. X spaces during sunday night football and just posting $dddx isn't doing it either. Website doesn't look like it's been updated in years either. Lots of talk but hoping they can actually deliver something.
Pretty dumb to have a X space on a sunday night with big football games being played. Jumped on for a few seconds and there was only about 4 people on the space. Very little trading volume the past few weeks too with only a few hundred or a couple of thousand $ traded. They're losing interest. All i see is them pumping their $DDDX on tweets and nothing newsworthy. Not great.
new post:
- remarkable healing properties. this is a recent case study they just posted. 7 weeks of treatments 3 times a day and save this guy from a below the knee amputation.Case Study: Non-Healing Diabetic Wound Treated & Healed to Save Below-the-knee Amputation https://t.co/Fh4Dh8rUNN
— ViaDerma (@viaderma) January 8, 2024
They said on X that the filings are coming soon. Although they're not always on shareholders timelines, they do end up getting the financials filed.
One of their reps said this during December and the last two weeks of the month most industry employees are wrapping up the year or taking PTO with vacation time. The filings will probably hit in the next week or two. It'll get done, we all hope.
The big news everyone is waiting for is stability testing and selling products internationally. They said in PRs and tweets to expect it by end of January and can immediately go to market right after in Q1.
Update on Stability Testing: We're on track to finalize all (finally!) within the next few weeks. Due to a small staining issue with the formulas at the testing facility, they've been working hard to correct this immediately. - Dr. Otiko
— ViaDerma (@viaderma) December 11, 2023
Cry louder basement dweller. You're a phony and everyone knows it. Move on he/she they/them.
Maybe this information will help the uniformed on this board.
https://tryvitastem.com/why-us/
The first two points especially.
1. Vitastem Ultra kills all known bacteria it has ever been tested against, including MRSA (flesh-eating bacteria) and Staph Infection.
2. Vitastem Ultra is the only antibiotic in the world that kills with both a physical and chemical mechanism, giving it a unique ability to defeat drug resistant bacteria.
What an absolute clown he/she they/them is. Just another parents basement dweller.
Overpriced? Most competing products are not very effective because of antibiotic resistance. Many other MRSA treatments in hospitals may run into the tens of thousands of dollars per treated patient.
$100 or even using 5 Vitastem Ultras for a nasty MRSA infection at $500 is substantially lower than most other prescription treatments.
Think you need to do some more research.
Thanks for the good laugh. WE ALL needed it.
Ask your dad's college girlfriend when you get upstairs from your parent's basement.
Have you read the recent PRs and posts on X? It seems like things are moving forward even though it's been slower than we all want but it seems there's finally a light at the end of the long tunnel.
When there is big news i am sure VDRM will be posting this everywhere.
Assuming the issue was uncovered in October and that's why it was delayed another 2-3 months? That would put it on a timeline to being finalized in January now. A big challenge with testing facilities is contamination. I have seen this happen with another medical product over the last year or so too. The issue knocked them back over a year with FDA protocols to get their product into the market. They're also on a January timeline now too.
Found this guide https://www.pharmaguideline.com/2012/02/guidelines-for-stability-study.html
It seems helpful. Vitastem currently has a shelf life for 2 years. My assumptions are they are siding on caution to make sure this is 100% ready to GTM in early 2024 to supply all the large volume orders in waiting that they announced in that previous press release.
Also, the tweets were signed by Dr Otiko. That's the first time I have ever seen that and he seems to be stepping up to the plate now. TBD but it seems VDRM is getting much closer to making some very big moves for the business.
Hopefully this the final hiccup with all the vitastem testing and they can get the sales moving internationally in 2024. Stability testing is usually a 6 to 12 month process and using third party testing partners often times run into issues. Seen similar issues like this with other OTC medical companies too. Fingers crossed bigger and better news is coming.
Very, very undervalued company right here! Lot of pending catalysts and news coming. DDDX is going to skyrocket IMO.
Looks like previous short sellers covered the past couple of days with low bid buyers scooping millions in new shares. https://www.otcshortreport.com/company/VDRM
OTC is about to take off again and make crypto like moves. IMO.
The next news updates should send this much, much higher.
Waiting on sales distribution news overseas. Yes. They'll be working with wholesalers over there. Not website sales.